Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2019
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 27 Dec 2017 Status changed from active, no longer recruiting to completed.
- 21 Aug 2013 Status changed from completed to active, no longer recruiting, as reported by ClincalTrials.gov.
- 21 Aug 2013 New source identified and integrated: ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History